Interferons in the Treatment of Solid Tumors

This publication has 189 references indexed in Scilit:

• Final results of the EORTC 18871/DKG 80-1 randomised phase III trial: rIFN-α2b versus rIFN-γ versus ISCADOR M® versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis
  Published by Elsevier ,2004
• Interferon-producing Cells Fail to Induce Proliferation of Naive T Cells but Can Promote Expansion and T Helper 1 Differentiation of Antigen-experienced Unpolarized T Cells
  The Journal of Experimental Medicine, 2003
• Multiple sclerosis and interferon β-1b, past, present and future
  Clinical Neurology and Neurosurgery, 2002
• Role for Surgical Cytoreduction in Multimodality Treatments for Cancer
  Annals of Surgical Oncology, 2001
• The host—tumor immune conflict: from immunosuppression to resistance and destruction
  Immunology Today, 1997
• Interferons combined with chemotherapy in the treatment of stage III-IV non-small cell lung cancer—a randomised study
  European Journal Of Cancer, 1994
• Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancer
  European Journal Of Cancer, 1993
• Natural interferon alfa as maintenance therapy for small cell lung cancer
  European Journal Of Cancer, 1992
• A dose-escalation study of recombinant interferon-alpha in patients with a metastatic carcinoid tumour
  European Journal Of Cancer, 1992
• Recombinant interferon a (IFL-rA) therapy of small cell and squamous cell carcinoma of the lung. A phase II study
  European Journal of Cancer and Clinical Oncology, 1987